Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL7259177

CC1CCCN1C.O=C(O)C(F)(F)F

nearest known ligand 0.41

Full drug profile on Sugi Atlas →

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
DPP4 P27487 2/20 0.40
DPP8 Q6V1X1 2/20 0.40
DRD2 P14416 1/20 0.39
DRD1 P21728 1/20 0.39
HRH3 Q9Y5N1 4/20 0.37
DPP7 Q9UHL4 1/20 0.36
CHRNB2 P17787 2/20 0.35
CHRNA4 P43681 2/20 0.35
CHRNA3 P32297 1/20 0.35
CHRNB3 Q05901 1/20 0.35
CHRNA6 Q15825 1/20 0.35
SLC2A1 P11166 1/20 0.35
CHRNA5 P30532 1/20 0.33
CHRNA7 P36544 1/20 0.33
GAA P10253 1/20 0.33
HPGD P15428 1/20 0.33
RECQL P46063 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Acetic Acid SCHEMBL27926986 0.83 RECQL (0.38) HRH3CHRNB2CHRNA4CHRNA3CHRNA5
Oxalic Acid SCHEMBL5857369 0.81 GAA (0.44) HRH3GAAHPGDRECQL
Trifluoroacetic Acid SCHEMBL28109182 0.81 DPP4 (0.46) DPP4DPP8DPP7GAAHPGD
Acetic Acid SCHEMBL9033618 0.79 GAA (0.43) HRH3GAAHPGDRECQL
Trifluoromethanesulfonic Acid SCHEMBL30212965 0.78 ACHE (0.36) DRD2DRD1HRH3
Trifluoroacetic Acid SCHEMBL30408711 0.78 CYP3A4 (0.37) DPP4DPP8DRD2DRD1DPP7
Trifluoroacetic Acid SCHEMBL3275665 0.78 CYP3A4 (0.37) DPP4DPP8DRD2DRD1DPP7
Trifluoroacetic Acid SCHEMBL27713091 0.78 DRD2 (0.43) DPP4DPP8DRD2DRD1HRH3
Trifluoroacetic Acid SCHEMBL30407660 0.78 CYP3A4 (0.37) DPP4DPP8DRD2DRD1DPP7
Trifluoroacetic Acid SCHEMBL6506374 0.78 EPHX1 (0.41) DPP4DPP8DRD2DRD1DPP7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116669721-B Anticholinergic agent 宁康瑞珠生物制药(珠海)有限公司 2025-03-18 CN disclosed
CN-116669721-A Anticholinergic agent 宁康瑞珠生物制药(珠海)有限公司 2023-08-29 CN disclosed
US-6545013-B2 Of squaric acids; inhibit the binding of integrins to their ligands and are of use in the prophylaxis and treatment of immuno or inflammatory disorders or disorders involving the inappropriate growth or migration of cells. CELLTECH R&D LIMITED (GB) 2003-04-08 US disclosed
EP-1286995-A1 2,7-NAPHTHYRIDINE DERIVATIVES Celltech R&D Limited (GB) 2003-03-05 EP disclosed
US-20020115684-A1 2, 7-naphthyridine derivatives CELLTECH R&D, LTD. (GB) 2002-08-22 US disclosed
WO-2001092256-A1 2,7-NAPHTHYRIDINE DERIVATIVES CELLTECH R & D LIMITED (GB) 2001-12-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020115684-A1 2, 7-naphthyridine derivatives VCAM1, ICAM1, SELL DPP4 3954/4885DPP8 4128/4885DRD2 1502/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.